![profile-img](https://pbs.twimg.com/profile_images/1537881775573110789/8Vgh2DJT_200x200.jpg)
Scott Haake, MD, PhD
@DrScottHaake
Excited to learn more about kidney cancer, biomarkers, integrins, and ECM biology. Views expressed are my own, not any institution’s. RT/like not endorsement.
02-12-2014 18:05:52
194 Tweets
739 Followers
1,9K Following
![Scott Haake, MD, PhD(@DrScottHaake) 's Twitter Profile Photo Scott Haake, MD, PhD(@DrScottHaake) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1537881775573110789/8Vgh2DJT_200x200.jpg)
#AnupamaReddy gave a great talk explaining the informatics behind our new RNAseq-based biomarker trial #OPTICRCC at #KCRS22 . Excited to launch this trial this! Use biology to choose 1st line therapy for ccRCC. Katy Beckermann Brian Rini, MD Vanderbilt-Ingram Cancer Center KidneyCAN #kidneycancer
![Scott Haake, MD, PhD (@DrScottHaake) on Twitter photo 2022-10-06 21:14:16 #AnupamaReddy gave a great talk explaining the informatics behind our new RNAseq-based biomarker trial #OPTICRCC at #KCRS22. Excited to launch this trial this! Use biology to choose 1st line therapy for ccRCC. @katy_beckermann @brian_rini @VUMC_Cancer @kidneycan #kidneycancer #AnupamaReddy gave a great talk explaining the informatics behind our new RNAseq-based biomarker trial #OPTICRCC at #KCRS22. Excited to launch this trial this! Use biology to choose 1st line therapy for ccRCC. @katy_beckermann @brian_rini @VUMC_Cancer @kidneycan #kidneycancer](https://pbs.twimg.com/media/FeamSACXkAA1Y52.jpg)